Scientists Are Optimistic About New Vaccine Studies From Novavax
Source: NY Times
By Carl Zimmer and Katie Thomas
The company has received a $1.6 billion grant from the government’s Operation Warp Speed to have 100 million doses ready by early 2021.
Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary studies on Tuesday.
In one study, 56 volunteers produced a high level of antibodies against the virus without any dangerous side effects. In the other, researchers found that the vaccine strongly protected monkeys from coronavirus infections.
Although it’s not possible to directly compare the…
View original post 371 more words